Particle.news

Download on the App Store

AHA Lowers Blood Pressure Target as Lancet Study Debuts Tool to Tailor Treatment

Clinicians gain a quantified roadmap for selecting regimens to achieve specified reductions, enabling earlier, target‑driven control.

Overview

  • The American Heart Association updated U.S. guidance to treat patients to keep blood pressure below 130/80 mmHg, moving intervention earlier in care.
  • Researchers at the George Institute introduced a calculator, published in The Lancet, that estimates average blood‑pressure reductions for medications and combinations using data from nearly 500 randomized trials involving over 100,000 people.
  • The tool classifies therapies by low, moderate, or high intensity to help match treatment plans to the reduction each patient requires.
  • Experts note that a single antihypertensive typically lowers systolic pressure by only 8–9 mmHg while many patients need 15–30 mmHg reductions, and they warn that variable blood‑pressure readings can obscure true treatment effects.
  • Hypertension affects about 1.3 billion people and causes roughly ten million deaths annually, and broader control could save many lives according to the study’s authors.